Results 11 to 20 of about 233,084 (265)

Role of Toll Like Receptor 4 in Alzheimer’s Disease

open access: yesFrontiers in Immunology, 2020
Long-term evidence has confirmed the involvement of an inflammatory component in neurodegenerative disorders including Alzheimer’s disease (AD). This view is supported, in part, by data suggesting that selected non-steroidal anti-inflammatory drugs ...
Maria Calvo-Rodriguez   +4 more
doaj   +1 more source

Toll-like Receptors and the Eye [PDF]

open access: yesInvestigative Opthalmology & Visual Science, 2006
The immune response to microbial pathogens relies on both innate and adaptive components.1 The innate or immediate response is mediated in large measure by leukocytes of the blood, such as neutrophils (PMNs) and macrophages, cells that phagocytose and kill the pathogens and that concurrently coordinate additional host responses by synthesis of a wide ...
Fu-Shin X, Yu, Linda D, Hazlett
openaire   +2 more sources

Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice.

open access: yesPLoS ONE, 2013
Systemic lupus erythematosus is an autoimmune disease with a high morbidity and nephritis is a common manifestation. Previous studies in murine lupus models have suggest a role for Toll-like receptor 2 and 4.
Simon J Freeley   +5 more
doaj   +1 more source

Role of toll like receptor 9 in developing systemic lupus erythematosus [PDF]

open access: yesRecords of Pharmaceutical & Biomedical Sciences, 2023
Systemic lupus erythematosus (SLE) is a systemic autoimmune illness caused by the collapse of immunological tolerance systems. It is a multisystemic autoimmune disease.
Fatma Mostafa   +2 more
doaj   +1 more source

The phosphoproteome of toll‐like receptor‐activated macrophages

open access: yesMolecular Systems Biology, 2010
Recognition of microbial danger signals by toll‐like receptors (TLR) causes re‐programming of macrophages. To investigate kinase cascades triggered by the TLR4 ligand lipopolysaccharide (LPS) on systems level, we performed a global, quantitative and ...
Gabriele Weintz   +10 more
doaj   +1 more source

Toll-like receptor signaling pathways

open access: yesFrontiers in Immunology, 2014
Toll-like receptors (TLRs) play crucial roles in the innate immune system by recognizing pathogen-associated molecular patterns derived from various microbes. TLRs signal through the recruitment of specific adaptor molecules, leading to activation of the
Taro eKawai, Takumi eKawasaki
doaj   +1 more source

Immunological study of orthodontically treated patients recovering from COVID-19 in Babylon Province, Iraq

open access: yesMedical Journal of Babylon, 2023
Background and Objectives: This study aimed to examine the levels of the toll-like receptors TLR4 and TLR2 in the blood and saliva of patients with coronavirus disease-2019 (COVID-19) receiving orthodontic care in Babylon Province. Materials and Methods:
Basma Abdel Khaleq Eidan   +2 more
doaj   +1 more source

Toll-like receptors in COPD [PDF]

open access: yesEuropean Respiratory Journal, 2017
TLR4 and NODs could be potential therapeutic targets in chronic obstructive pulmonary diseasehttp://ow.ly ...
Hansbro, Philip M.   +3 more
openaire   +2 more sources

Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer

open access: yesTumor Biology, 2018
Toll-like receptors play an essential role in our innate immune system and are a focus of interest in contemporary cancer research. Thus far, Toll-like receptors have shown promising prognostic value in carcinomas of the oral cavity, colon, and ovaries ...
Mira A Lanki   +6 more
doaj   +1 more source

Toll-Like Receptors in Angiogenesis [PDF]

open access: yesThe Scientific World JOURNAL, 2011
Toll-like receptors (TLRs) are known as pattern-recognition receptors related to the Toll protein ofDrosophila. After recognition of pathogen-associated molecular patterns of microbial origin, the TLRs alert the immune system, and initiate innate and adaptive immune responses.
Karsten Grote   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy